Tacrolimus delivered from polymeric implants suppressed inflammation and angiogenesis in vivo without inducing nephrotoxicity, hepatotoxicity, and myelosuppression-Reference-Cited by-同舟云学术

Tacrolimus delivered from polymeric implants suppressed inflammation and angiogenesis in vivo without inducing nephrotoxicity, hepatotoxicity, and myelosuppression

Published:2018-02 Issue: Volume:43 Page:487-495
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

De Oliveira Leandro Gonzaga,De Miranda Marina Barcelos,De Moura Sandra Aparecida Lima^ORCID,Da Silva Gisele Rodrigues^ORCID

Funder

CNPq/MCT (Brazil)

FAPEMIG

UFSJ

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. The mechanism of action of cyclosporin A and FK506;Schreiber;Trends. Immunol.,1992

2. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy;Taylor;Crit. Rev. Oncol. Hematol.,2005

3. FK506, an immunosuppressant targeting calcineurin function;Dumont;Curr. Med. Chem.,2000

4. Distinctive calcineurin-dependent (FK506-Sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1a, MIP-1b, and RANTES vs IL-2 and TNF-α by activated human T cells;Staruch;Cell Immunol.,1998

5. T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model;Van Lierop;Inflamm. Bowel Dis.,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in local drug delivery technologies for improved rheumatoid arthritis therapy;Advanced Drug Delivery Reviews;2024-06

2. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities;Journal of Controlled Release;2021-02

3. Matrices, scaffolds, and carriers for protein and molecule delivery in peripheral nerve regeneration;Experimental Neurology;2019-09

4. Intra-articular leflunomide-loaded poly(epsilon-caprolactone) implants to treat synovitis in rheumatoid arthritis;PHARMAZIE;2019